Delivery Order SPE2DB22D3016-SPE2DB25FBGW6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,562.33 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 tablets of Escitalopram 10 mg, valued at $3,558.49 under a firm fixed-price contract. This delivery order represents a non-competitive, non-set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The pharmaceutical product is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Escitalopram 20 mg tablets in a quantity of 1,000 units, with a firm fixed price ceiling value of $4,295.66. The contract represents a non-set-aside, competitively awarded procurement with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg on July 29, 2025, with a ceiling value of $2,187.18 and an ultimate completion date of July 30, 2025. The contract carries a firm fixed price with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for 4,563,955,449 units of the medication Escitalopram 10 mg tablet. The contract has a total ceiling value of $10,658.61 and an ultimate completion date of March 14, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,250 units of the pharmaceutical drug Escitalopram 10 mg tablets. The $1,757.34 contract has a performance period ending on January 8, 2024 and will be executed from Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp has a long history of providing pharmaceutical products and...
- This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,034.80 firm fixed-price delivery order is for the supply of 1,000 tablets of the drug Escitalopram 10 mg. The contract has an ultimate completion date of April 7, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range...
- The Defense Logistics Agency awarded a delivery order valued at $1,262.89 to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, a selective serotonin reuptake inhibitor commonly prescribed for depression and anxiety disorders. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,761.77 to Amerisourcebergen Drug Corp, a for-profit corporation based in Conshohocken, Pennsylvania. The contract is for the supply of 1,000 units of the prescription medication Escitalopram 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary...
- The Defense Logistics Agency awarded a $12,829.10 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of escitalopram 10 mg. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of four days from September 1 through September 5, 2023. No...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGW6Delivery Order
The Defense Logistics Agency awarded a $1,627.52 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Escitalopram 10 mg, with performance scheduled for completion by September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements. This award is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through multiple therapeutic domains and maintains an established capability to meet Defense Logistics Agency requirements across its extensive product portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/2/25 |